Insider · CIK 0001266163

BALL KRISTINE M

Reports to the SEC for 6 companies · MENLO PARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001266163

Forms 4 and 5

Insider transactions

49 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-02	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,136 sh	—	—	9,136
2025-06-02	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2023-06-13	Atreca, Inc.Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2022-06-08	Atreca, Inc.Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2021-06-09	Atreca, Inc.Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2020-06-10	Atreca, Inc.Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2020-05-20	Atreca, Inc.Stock Option (right to buy)A Award	Director	AAward	+24K sh	—	—	24,000
2020-04-07	Forty Seven, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−69.7K sh	—	—	0
2020-04-07	Forty Seven, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.3K sh	—	—	0
2019-12-11	YARWYarrow Bioscience, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+80.3K sh	—	—	80,300
2019-12-11	YARWYarrow Bioscience, Inc.F Tax Payment	See Remarks	FTax Payment	−27.8K sh	$4.52	−$126K	52,534
2019-12-11	YARWYarrow Bioscience, Inc. · Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−80.3K sh	—	—	0
2019-12-11	YARWYarrow Bioscience, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+80.3K sh	—	—	80,300
2019-12-11	YARWYarrow Bioscience, Inc.F Tax Payment	See Remarks	FTax Payment	−27.8K sh	$4.52	−$126K	52,534
2019-07-29	YARWYarrow Bioscience, Inc. · Restricted Stock UnitsA Award	See Remarks	AAward	+80.3K sh	—	—	413,423
2019-07-29	YARWYarrow Bioscience, Inc. · Restricted Stock UnitsA Award	See Remarks	AAward	+80.3K sh	—	—	413,423
2019-06-12	Forty Seven, Inc.Stock Option (right to buy)A Award	Director	AAward	+10.3K sh	—	—	10,322
2018-12-10	YARWYarrow Bioscience, Inc. · Stock OptionA Award	See Remarks	AAward	+96K sh	—	—	96,000
2018-05-03	YARWYarrow Bioscience, Inc. · Stock OptionA Award	See Remarks	AAward	+64K sh	—	—	237,123
2016-09-01	Relypsa IncStock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer & SVP	DDisposition to Issuer	−25K sh	—	—	0
2016-09-01	Relypsa IncA Award	Chief Financial Officer & SVP	AAward	+4,167 sh	—	—	32,277
2016-09-01	Relypsa IncU Disposition from Tender	Chief Financial Officer & SVP	UDisposition from Tender	−11.9K sh	$32.00	−$382K	20,355
2016-09-01	Relypsa IncD Disposition to Issuer	Chief Financial Officer & SVP	DDisposition to Issuer	−20.4K sh	$32.00	−$651K	0
2016-09-01	Relypsa IncStock Option (Right to Buy)A Award	Chief Financial Officer & SVP	AAward	+16.7K sh	—	—	25,000
2016-09-01	Relypsa IncStock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer & SVP	DDisposition to Issuer	−123K sh	—	—	0
2016-09-01	Relypsa IncStock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer & SVP	DDisposition to Issuer	−43.6K sh	—	—	0
2016-09-01	Relypsa IncStock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer & SVP	DDisposition to Issuer	−35K sh	—	—	0
2016-09-01	Relypsa IncStock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer & SVP	DDisposition to Issuer	−38.5K sh	—	—	0
2016-08-15	Relypsa IncF Tax Payment	Chief Financial Officer & SVP	FTax Payment	−1,480 sh	$31.89	−$47.2K	28,110
2016-06-03	Relypsa IncStock Option (Right to Buy)A Award	Chief Financial Officer & SVP	AAward	+8,333 sh	—	—	8,333
2016-06-03	Relypsa IncA Award	Chief Financial Officer & SVP	AAward	+2,083 sh	—	—	30,373
2016-06-03	Relypsa IncF Tax Payment	Chief Financial Officer & SVP	FTax Payment	−783 sh	$19.96	−$15.6K	29,590
2016-03-16	Relypsa IncP Purchase	Chief Financial Officer & SVP	PPurchase	+7,000 sh	$12.15	+$85.1K	28,290
2015-11-06	Relypsa IncA Award	Chief Financial Officer & SVP	AAward	+6,250 sh	—	—	21,290
2015-09-02	Relypsa IncS Sale	Chief Financial Officer & SVP	SSale	−646 sh	$22.96	−$14.8K	15,040
2015-08-17	Relypsa IncS Sale	Chief Financial Officer & SVP	SSale	−710 sh	$24.78	−$17.6K	15,040
2015-08-10	Relypsa IncStock Option (right to buy)A Award	Chief Financial Officer & SVP	AAward	+38.5K sh	—	—	38,500
2015-08-10	Relypsa IncA Award	Chief Financial Officer & SVP	AAward	+8,250 sh	—	—	15,750
2015-03-05	Relypsa IncS Sale	Chief Financial Officer & SVP	SSale	−3,000 sh	$41.00	−$123K	7,500
2015-03-05	Relypsa IncM Exercise/Conversion	Chief Financial Officer & SVP	MExercise/Conversion	+3,000 sh	$3.96	+$11.9K	10,500
2015-03-05	Relypsa IncStock Option (right to buy)M Exercise/Conversion	Chief Financial Officer & SVP	MExercise/Conversion	−3,000 sh	—	—	122,872
2015-03-03	Relypsa IncS Sale	Chief Financial Officer & SVP	SSale	−519 sh	$38.80	−$20.1K	7,500
2015-01-21	Relypsa IncStock Option (right to buy)M Exercise/Conversion	Chief Financial Officer & SVP	MExercise/Conversion	−3,000 sh	—	—	125,872
2015-01-21	Relypsa IncM Exercise/Conversion	Chief Financial Officer & SVP	MExercise/Conversion	+3,000 sh	$3.96	+$11.9K	10,500
2015-01-21	Relypsa IncS Sale	Chief Financial Officer & SVP	SSale	−3,000 sh	$36.00	−$108K	7,500
2014-08-14	Relypsa IncA Award	Chief Financial Officer & SVP	AAward	+7,500 sh	—	—	7,500
2014-08-14	Relypsa IncStock Option (right to buy)A Award	Chief Financial Officer & SVP	AAward	+35K sh	—	—	35,000
2003-11-12	EXELEXELIXIS, INC.S Sale	Controller & Interim CFO	SSale	−4,674 sh	$7.01	−$32.8K	4,913
2003-11-11	EXELEXELIXIS, INC.S Sale	Controller & Interim CFO	SSale	−8,700 sh	$6.92	−$60.2K	9,587

Recent filings

Accepted (ET)
Jun 34
BALL KRISTINE M0000907654-26-000049
SEC(opens sec.gov)
Jun 34
BALL KRISTINE M0001062993-25-010822
SEC(opens sec.gov)
Jun 154
BALL KRISTINE M0001209191-23-037515
SEC(opens sec.gov)
Jun 104
BALL KRISTINE M0001209191-22-036109
SEC(opens sec.gov)
Jun 114
BALL KRISTINE M0001209191-21-039850
SEC(opens sec.gov)
Jun 154
BALL KRISTINE M0001209191-20-036674
SEC(opens sec.gov)
May 214
BALL KRISTINE M0001209191-20-031451
SEC(opens sec.gov)
Apr 74
BALL KRISTINE M0001209191-20-023717
SEC(opens sec.gov)
Dec 164/A
BALL KRISTINE M0000899243-19-029293
SEC(opens sec.gov)
Dec 134
BALL KRISTINE M0000899243-19-029188
SEC(opens sec.gov)
Aug 74/A
BALL KRISTINE M0000899243-19-021295
SEC(opens sec.gov)
Jul 314
BALL KRISTINE M0000899243-19-020703
SEC(opens sec.gov)
Jun 144
BALL KRISTINE M0001209191-19-037265
SEC(opens sec.gov)
Dec 124
BALL KRISTINE M0001566044-18-000010
SEC(opens sec.gov)
May 44
BALL KRISTINE M0001209191-18-028121
SEC(opens sec.gov)
Sep 24
Relypsa Inc0001140361-16-078616
SEC(opens sec.gov)

Companies

Address

C/O ORUKA THERAPEUTICS, INC. 855 OAK GROVE AVE., SUITE 100

MENLO PARK, CA, 94025